CEO:Dr. Christopher U. Missling M.B.A., M.S., Ph.D.
Full-time employees:38
City:New York
Address:51 West 52nd Street
IPO:2006-08-02
CIK:0001314052
Website:
Return on Investments
The company's asset efficiency, represented by a robust -0.291% return, is a testament to Anavex Life Sciences Corp.'s adeptness in optimizing resource deployment. Anavex Life Sciences Corp.'s utilization of its assets to generate profits is strikingly evident through a noteworthy return on equity of -0.303%. Furthermore, the proficiency of Anavex Life Sciences Corp. in capital utilization is underscored by a remarkable -0.361% return on capital employed.
Stock Prices
Anavex Life Sciences Corp.'s stock prices have been subject to undulating patterns. The peak stock value during this interval surged to $3.85, while its low point bottomed out at $3.53. This variance in figures offers investors a lucid insight into the roller-coaster ride that is Anavex Life Sciences Corp.'s stock market.
Liquidity Ratios
Analyzing AVXL liquidity ratios reveals its financial health of the firm.
The current ratio of 1185.03% gauges short-term asset coverage for liabilities.
The quick ratio (1178.98%) assesses immediate liquidity, while the cash ratio (1150.58%) indicates cash reserves.
cards.indicator
cards.value
Current Ratio
1185.03%
Quick Ratio
1178.98%
Cash Ratio
1150.58%
Profitability Ratios
The effective tax rate stands at -0.26%, revealing its tax efficiency.
The net income per EBT, 100.26%, and the EBT per EBIT, 88.01%, provide insights into its earnings hierarchy.
cards.indicator
cards.value
Effective Tax Rate
-0.26%
Net Income per EBT
100.26%
EBT per EBIT
88.01%
Operational Efficiency
Operational metrics shed light on its business agility. With an operating cycle of 11.85, it details the span from stock purchase to revenue.
The 12 days it takes to settle debts showcases its creditor relations.
cards.indicator
cards.value
Days of Sales Outstanding
1179
Cash Flow Ratios
Peering into the cash flow metrics reveals liquidity and operational efficiency. The operating cash flow per share, -0.36, and free cash flow per share, -0.36, depict cash generation on a per-share basis.
The cash per share value, 1.75, showcases liquidity position.
cards.indicator
cards.value
Operating Cash Flow per Share
-0.36
Free Cash Flow per Share
-0.36
Cash per Share
1.75
Free Cash Flow to Operating Cash Flow Ratio
1.00
Debt and Leverage Ratios
An interest coverage of 43.20 indicates its ability to manage interest expenses.
cards.indicator
cards.value
Interest Coverage
43.20
Company Equity Multiplier
1.09
Per Share Data
Net income per share, -0.60, reflects the portion of profit attributed to each share.
The book value per share, 1.78, represents the net asset value distributed per share, while the tangible book value per share, 1.78, excludes intangible assets.
cards.indicator
cards.value
Net Income Per Share
-0.60
Book Value Per Share
1.78
Tangible Book Value Per Share
1.78
Shareholders Equity Per Share
1.78
Interest Debt Per Share
0.01
Growth Ratios
EBIT growth, 12.68%, and operating income growth, 12.68%, offer insights into operational profitability progression.
The net income growth, 1.01%, showcases bottom-line expansion, and the EPS growth, 3.23%, measures the growth in earnings per share.
cards.indicator
cards.value
EBIT Growth
12.68%
Operating Income Growth
12.68%
Net Income Growth
1.01%
EPS Growth
3.23%
EPS Diluted Growth
3.23%
Weighted Average Shares Growth
3.74%
Weighted Average Shares Diluted Growth
3.74%
Operating Cash Flow Growth
-14.63%
Free Cash Flow Growth
-14.63%
10-Year Operating CF Growth per Share
-257.26%
5-Year Operating CF Growth per Share
-23.59%
3-Year Operating CF Growth per Share
4.80%
10-Year Net Income Growth per Share
-28.33%
5-Year Net Income Growth per Share
-52.29%
3-Year Net Income Growth per Share
-31.80%
10-Year Shareholders Equity Growth per Share
675.76%
5-Year Shareholders Equity Growth per Share
287.44%
3-Year Shareholders Equity Growth per Share
279.87%
Receivables Growth
-15.15%
Asset Growth
1.10%
Book Value per Share Growth
-4.04%
R&D Expense Growth
15.30%
SGA Expenses Growth
-7.89%
Other Metrics
Venturing into other key metrics unveils diverse facets of financial performance. The enterprise value, 371,584,753.8, captures the company's total value, considering both debt and equity.
Income quality, 0.58, assesses the reliability of reported earnings.
cards.indicator
cards.value
Enterprise Value
371,584,753.8
Income Quality
0.58
Graham Number
4.88
Return on Tangible Assets
-30.76%
Graham Net Net
1.76
Working Capital
141,852,000
Tangible Asset Value
141,852,000
Net Current Asset Value
141,852,000
Average Receivables
2,950,790
Average Payables
4,073,388.5
ROIC
-33.48%
ROE
-0.33%
Valuation Ratios
Exploring the valuation ratios offers insights into perceived market value. The price to book value ratio, 2.35, and the price to book ratio, 2.35, reflect the market's valuation relative to the company's book value.
Ratios like price to free cash flows, -10.70, and price to operating cash flows, -10.87, gauge market valuation against cash flow metrics.
cards.indicator
cards.value
Price Book Value Ratio
2.35
Price to Book Ratio
2.35
Price Cash Flow Ratio
-10.87
Price Earnings to Growth Ratio
-2.29
Enterprise Value Multiple
-9.80
Price Fair Value
2.35
Price to Operating Cash Flow Ratio
-10.87
Price to Free Cash Flows Ratio
-10.70
Price to Tangible Book Ratio
3.68
Enterprise Value Over EBITDA
-7.82
EV to Operating Cash Flow
-13.37
Earnings Yield
-9.09%
Free Cash Flow Yield
-5.32%
Trusted project
“All information displayed on the site is verified. High quality project and financial performance”
